Acute priapism associated with the use of sildenafil in a patient with sickle cell trait-Reference-Cited by-同舟云学术

Acute priapism associated with the use of sildenafil in a patient with sickle cell trait

Published:2000-03-01 Issue:5 Volume:95 Page:1878-1879
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Kassim Adetola A.¹,Fabry Mary E.¹,Nagel Ronald L.¹

Affiliation:

1. Division of Hematology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/95/5/1878/1661154/1878.pdf

Reference9 articles.

1. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group [see comments] [published erratum appears in N Engl J Med 1998 Jul 2;339(1):59].;Goldstein;N Engl J Med.,1998

2. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.;Morales;Int J Impot Res.,1998

3. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group [see comments].;Padma-Nathan;Int J Clin Pract.,1998

4. Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia.;Nagel;Semin Hematol.,1991

5. Priapism and impotence in homozygous sickle cell disease.;Emond;Arch Intern Med.,1980

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications mostly associated with priapism events: assessment of the 2015–2020 Food and Drug Administration (FDA) pharmacovigilance database entries;International Journal of Impotence Research;2022-05-21

2. Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion;Blood Advances;2021-12-02

3. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction;Sexual Medicine Reviews;2018-04

4. Urologic Emergencies;Medical Clinics of North America;2018-03

5. Phosphodiesterase type V inhibitors;Meyler's Side Effects of Drugs;2016